TTRX logo
TTRX NASDAQ US

Turn Therapeutics Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Oct 2025
$3.35
▲ +$0.24 (+7.54%)
Vol 39K
2
Quality Score
fail
Beta
3.17
52W
$3–$27

Wall Street Consensus

8 analysts · Apr 2026
2
Strong Buy
5
Buy
1
Hold
0
Sell
0
Strong Sell
87.5%
Buy Rating

Price Chart

Fundamentals Trend

Metric 2025-11-03 2025-12-03 2026-01-02
ROE (TTM)
P/E (TTM)
Net Margin
Gross Margin
D/E Ratio
Current Ratio

Key Ratios

52W High
$26.50
52W Low
$2.57
$2.57 52-Week Range $26.50

How does TTRX compare to Pharmaceuticals peers?

Peer group: Micro-cap Pharmaceuticals (All) · 171 companies

TTRX AARD ACB ACRS ADIL

TTRX valuation vs Pharmaceuticals peers

P/E ratio
0% below peers (22.4)
vs Peers
vs Industry
Undervalued
P/S ratio
0% below peers (5.0)
vs Peers
vs Industry
Overvalued
P/B ratio
0% below peers (2.1)
vs Peers
vs Industry
Overvalued
Div yield
0% below peers (2.0%)
vs Peers
vs Industry
Low yield

TTRX profitability vs Pharmaceuticals peers

ROE
0% below peers (-54.3%)
vs Peers
vs Industry
Top tier
Net margin
0% below peers (-47.4%)
vs Peers
vs Industry
Top tier
Gross margin
0% below peers (68.3%)
vs Peers
vs Industry
In line
ROA
0% below peers (-37.4%)
vs Peers
vs Industry
Top tier

TTRX financial health vs Pharmaceuticals peers

D/E ratio
0% below peers (1.5)
vs Peers
vs Industry
High debt
Current ratio
0% below peers (3.4)
vs Peers
vs Industry
Strong liquidity
Beta
3.2
237% above peers (0.9)
vs Peers
vs Industry
More volatile

TTRX fundamentals radar

TTRX Peer median Industry

TTRX profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

TTRX vs peers: key metrics

Latest News

No related news yet